PharmaVoice

JANUARY 27, 2025

Coya Therapeutics is entering into a phase 2b study for its ALS, and the biotech’s CEO believes it’s on the cusp of a game changer.

279

279

Drug Topics

JANUARY 27, 2025

Researchers analyzed overall prescription stimulant dispensing trends among US children from 2017 to 2023.

247

247

PharmaVoice

JANUARY 27, 2025

These innate immune cells may provide a safer, lower-cost option in cancer and autoimmune diseases.

Immunization 182

Immunization 182

Drug Topics

JANUARY 27, 2025

A discussion with Natalie DiPietro Mager, PharmD, PhD, on how community pharmacists can improve access to contraceptive services.

247

247

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Pharmacy Times

JANUARY 27, 2025

Administered every 4 weeks, the approval could serve as a breakthrough for easier and more effective care for patients with early Alzheimer disease.

FDA 133

FDA 133

Drug Topics

JANUARY 27, 2025

Eric Tichy, PharmD, MBA, sat down with Drug Topics to discuss challenges within the business behind health-system pharmacies.

247

247

Pharmacy Times

JANUARY 27, 2025

Based on the updated label, new pharmacodynamic data have been added for a better understanding of the drug for individuals with attention-deficit/hyperactivity disorder (ADHD).

Labelling 122

Labelling FDA 122

pharmaphorum

JANUARY 27, 2025

A GSK alliance with Oxford University aims to identify precancerous changes in cells that could form the basis of preventive vaccines.

Vaccines 118

Vaccines 118

The Happy PharmD

JANUARY 27, 2025

Theres something big happening in healthcare right now. Its a trend thats becoming impossible to ignore. Doctors, nurses, pharmacists, physician assistants, and others are leaving their roles in droves, and the truth is, the consequences are already being felt. Healthcare, a system that weve relied on for generations, is in crisis and the people who are supposed to be helping are being stretched too thin, leading to unfulfilled positions and a growing sense of uncertainty.

52

52

Pharmacy Times

JANUARY 27, 2025

Cannabis use during pregnancy may harm fetal development and long-term health.

111

111

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

pharmaphorum

JANUARY 27, 2025

Pfizer has paid $60m to settle US government allegations that its Biohaven unit made improper payments to prescribers of its migraine drug Nurtec ODT.

105

105

Pharmacy Times

JANUARY 27, 2025

Antiviral treatments for respiratory viruses such as respiratory syncytial virus (RSV) are crucial, especially with the rise of the "triple-demic.

110

110

pharmaphorum

JANUARY 27, 2025

Stay ahead of the game by keeping an eye on these six life sciences real estate trends to watch in 2025. From AI integration to collaborative incubator spaces, the industry is evolving rapidly.

104

104

Pharmacy Times

JANUARY 27, 2025

Managing bispecific antibodies requires collaboration and meticulous protocols.

109

109

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmaceutical Technology

JANUARY 27, 2025

Biohaven, acquired by Pfizer in 2022, allegedly took doctors to high-end restaurants and paid speaker honoraria for preferential prescriptions.

104

104

pharmaphorum

JANUARY 27, 2025

China's Ascentage completes the first US biotech IPO of 2025, raising $126m for its pipeline of small-molecule cancer drugs.

98

98

Roots Analysis

JANUARY 27, 2025

Benefits offered by microbial manufacturing, such as low production costs and faster development timelines, have led many innovators to adopt microbial fermentation for next generation biologics, offering lucrative opportunities for microbial CMOs / CDMOs. Within microbial fermentation market, service providers presently claim to have most of the microbial production capacity, driving innovators to outsource their manufacturing needs and shift their focus on research and development efforts.

Vaccines 40

Vaccines 40

pharmaphorum

JANUARY 27, 2025

UK firm Swarm Oncology launches with a T-cell therapy platform to treat solid tumours, with a Resolution Therapeutics co-founder in the pilot seat.

83

83

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Roots Analysis

JANUARY 27, 2025

Over the years, the incidence and prevalence of chronic diseases, such as diabetes, multiple sclerosis and rheumatoid arthritis, have increased significantly. This has led to the growing research and development towards the development of biologics for therapy purpose. These biologics are generally administered through parenteral route of administration in order to ensure maximum therapeutic benefit.

Hospitals 40

Hospitals Packaging Compounding Immunization 40

Pharmacy Times

JANUARY 27, 2025

Approximately 66% of patients received a COVID-19 vaccine in the fall of 2024 and only 26% received a respiratory syncytial virus vaccine.

Vaccines 82

Vaccines 82

The Checkup by Singlecare

JANUARY 27, 2025

Propranolol is a generic prescription medication sold under different brand names, such as Inderal LA, Inderal XL, Hemangeol, and InnoPran XL. It is used to treat cardiovascular conditions such as high blood pressure, conditions that cause irregular heartbeat, heart failure, and heart attacks. Propranolol belongs to a class of medication called beta blockers.

Dosage 78

Dosage 78

The Guardian - Pharmaceutical Industry

JANUARY 27, 2025

Collaboration over at least three years aims to help understand how pre-cancerous cells develop Business live latest updates GSK has said it will spend 50m on a project with the University of Oxford to investigate whether vaccines could be used to prevent some cancers. The FTSE 100 pharmaceutical company said that the GSK-Oxford Cancer Immuno-Prevention Programme will look at how pre-cancerous cells develop.

Vaccines 77

Vaccines Pharmaceutical Companies Pharmaceutical Companies 77

Fierce Healthcare

JANUARY 27, 2025

Health Care Service Corporation is facing new pressure from providers over its upcoming policy change to coverage of in-office asthma infusion treatment.

75

75

Pharmacy Times

JANUARY 27, 2025

Patients with myelofibrosis have a higher likelihood of having a cardiovascular risk factor when compared with essential thrombocythemia or polycythemia vera.

73

73

Pharmaceutical Technology

JANUARY 27, 2025

With continued investment and growing buzz from the industry, the AI hype is expected to extend through 2025 and beyond.

71

71

Pharmacy Times

JANUARY 27, 2025

Remission is a new emphasis and treatment goal for the management of asthma.

73

73

Pharmaceutical Technology

JANUARY 27, 2025

Tevogen Bio has expanded its partnership with Microsoft, aiming to further their collaboration centred on AI and advance PredicTcell.

69

69

pharmaphorum

JANUARY 27, 2025

Oncopeptides hopes to reignite growth in multiple myeloma drug Pepaxti after getting reimbursement approval in Italy.

68

68

Fierce Healthcare

JANUARY 27, 2025

The "broad framework" outlined by the partners would address healthcare issues in the state, such as high costs and workforce shortages, with $1 billion of new investments over the next half decade.

68

68

Pharmacy Times

JANUARY 27, 2025

Axatilimab-csfr is a colony-stimulating factor-1 receptor (CSFR1) blocking monoclonal antibody indicated for cGVHD after 2 or more lines of prior therapy in adults and pediatric patients that weigh at least 40 kg.

65

65

Fierce Healthcare

JANUARY 27, 2025

The nonprofit logged a 1.7% operating margin for 2024, well below the target 2.7%. In response, the system sought "efficiencies in how we manage our organization" that include a 3% cut to administrative management.

63

63

Pharmacy Times

JANUARY 27, 2025

Although the research focused on Black communities in the United States, there is also evidence linking racism and blood pressure for patients who are Asian or Hispanic.

65

65

STAT

JANUARY 27, 2025

  Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds.  Sign up here.

60

60